Global Liquid Biopsy Market Forecast 2018-2026
Agenda
Key Findings Market Insights
Regional Insights
Competitive Insights
Left Image Slide Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy. Various versions have evolved.
Key Findings • Developments in precision medicines, increasing prevalence of cancer cases in the elderly population and supportive government initiatives are factors that are contributing to the expansion of the Liquid –Biopsy market. • Over the forecast period of 2018-2026, the global liquid biopsy market is expected to rise at a CAGR of 22.97%.
Market Insights •
The Global Liquid Biopsy market is segmented into Biomarker types, Indication, Analysis Platform, Products, Analysis purpose, and End users.
•
The biomarker types include nucleic acids, proteins, extracellular vesicles and cells.
•
The Indication segment of the market can further be classified cancer indications, NIPT, and Transplant. The analysis platform of this market includes Microarray, NGS, Proteomics, PCR, and other analysis platform.
•
The products for this market can be further classified into exosomes, CTCS and CTDNA products.
•
The Analysis purpose for this market is for Therapy guidance, early detection/screening, monitoring and diagnosis.
•
The end-users for this market are Hospitals, Physicians ‘office laboratories’, and Clinical diagnostic laboratories.
Image Slide
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
The Global Liquid Biopsy Market is expected to rise at a CAGR of 22.97%, over the forecast period of 2018-2026. Request Free Sample
Competitive Insights Some of the leading market players in the global liquid biopsy market are Agilent Technologies Inc, Ad-Tech Medical Instrument Corp, Argon Medical Devices Inc, Becton, B. Braun Melsungen Ag, Dickinson, Bio-Rad Laboratories Inc, Boston Scientific Corporation, C. R. Bard, Inc, Cook Group Inc, Cintec Medical Ltd, Fischer Medical Technologies Llc, Planmeca Oy, I.M.S. Internazionale Medico Scientifica Srl,Roche Diagnostics Ltd, and Qiagen N.V.